New Bcl10 regulation mechanisms: A step in the comprehension of which has occurred in MALT lymphomas?;Nouveaux mécanismes régulateurs de Bcl10: Une avancée dans la compréhension de la survenue des lymphomes du MALT?

Medecine/Sciences

Volumn 23, Issue 4, 2007, Pages 353-355

  Lobry, Camille ^a   Weil, Robert ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; PROTEIN BCL 10;

CHROMOSOME TRANSLOCATION; HUMAN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NOTE; PROTEIN ANALYSIS; REGULATORY MECHANISM;

EID: 34247229581     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2007234353     Document Type: Note

References (13)

1. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006 ; 441 : 431-6.
2. Weil R, Israël A. Deciphering the pathway from the TCR to NF-kappaB. Cell Death Differ 2006 ; 13 : 826-33.
3. Ruefli-Brasse AA, Lee WP, Hurst S, Dixit VM. Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappa B activation. J Biol Chem 2003 ; 279 : 1570-74.
4. 2+/calmodulin-dependent protein kinase II. Mol Immunol 2007 ; 44 : 2105-10.
5. Wegener E, Oeckinghaus A, Papadopoulou N, et al. Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-MALT1 complexes upon T cell activation. Mol Cell 2006 ; 23 : 13-23.
6. Scharschmidt E, Wegener E, Heissmeyer V, et al. Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling. Mol Cell Biol 2004 ; 24 : 3860-73.
7. Hu S, Alcivar A, Qu L, et al. CIAP2 inhibits antigen receptor signaling by targeting Bcl10 for degradation. Cell Cycle 2006 ; 5 : 1438-42.
8. Lobry C, Lopez T, Israel A, Weil R. Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10. Proc Natl Acad Sci USA 2007 ; 104 : 908-13.
9. Liu Y, Dong W, Chen L, et al. Characterization of Bcl10 as a potential transcriptional activator that interacts with general transcription factor TFIIB. Biochem Biophys Res Commun 2004 ; 320 : 1-6.
10. Lee SH, Shin MS, Kim HS, et al. Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas. Cancer Res 1999 ; 59 : 5674-7.
11. Willis TG, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999 ; 96 : 35-45.
12. Wu G, Xu G, Schulman BA, et al. Structure of beta-TrCP-Skp1-beta- catenin complex: destruction motif binding and lysine specificity of the SCFbeta-TrCP1 ubiquitin ligase. Mol Cell 2003 ; 11 : 1445-56.
13. Chan EF, Gat U, McNiff JM, Fuchs E. A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet 1999 ; 21 : 410-3.